BRAF and colorectal carcinoma: Next, we detected the AIM2 expression in BRAF inhibitor PLX8394-treated BRAF-mutant CRC cells, we found that BRAF inhibitor administration enhanced AIM2 expression, indicating that BRAF inhibition could restore AIM2 expression in CRC cell lines (Supplementary Figure 1).